soul trial oral semaglutide cardiovascular outcomes 2024 results mace reduction (Semaglutide triaL) in individuals with SOUL trial: Oral semaglutide demonstrates – Cardio-kidney-metabolic protective effects of semaglutide – SOUL: Oral Semaglutide Cuts MACE

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1) medication prescribed to manage Type 2 diabetes, reduce the risk of cardiovascular events like heart attacks, and assist with chronic weight management

If one of us is going through something, we are just a call away. Sign up here for a weekly roundup of The Upside, sent to you every Sunday Bored at work

Coenzyme Q10 (CoQ10) Key role in ATP (energy) production in mitochondria Strong antioxidant protects cells from oxidative damage Enhances egg quality and sperm motility Supports cardiovascular health 2

Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study

Cvetanovi KljakiABounoviJGaiUSeebaluck-SandoramRUbaAIMahomoodallyMFet al